Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs999885
rs999885
0.020 GeneticVariation BEFREE These findings indicate that the A to G base change of rs999885 may provide a protective effect on the prognosis of intermediate or advanced HCC in Chinese. 24416400

2014

dbSNP: rs999885
rs999885
0.020 GeneticVariation BEFREE These findings indicate that the A to G base change of rs999885 may provide a protective effect against chronic HBV infection but an increased risk for HCC in HBV persistent carriers by altering the expression of the miR-106b-25 cluster. 22393390

2012

dbSNP: rs9970827
rs9970827
0.010 GeneticVariation BEFREE Our results indicated that rs12309362 (G > A), rs9970827 (A > G) in DHSs, and elevated expression of CEBPB were associated with a decreased risk of HCC. 28321907

2017

dbSNP: rs9967368
rs9967368
0.010 GeneticVariation BEFREE Two SNPs (rs523230 and rs9967368) in TYMS gene were significantly associated with the overall survival of HCC patients. 28043790

2017

dbSNP: rs9966765
rs9966765
0.010 GeneticVariation BEFREE There was also a significant increased risk of HCC when combining risk genotypes of these loci, i.e., rs1135519 CC and rs9966765 CC. 30662901

2018

dbSNP: rs9926344
rs9926344
0.010 GeneticVariation BEFREE <b>Conclusion:</b> Our findings indicate that WWOX rs9926344 polymorphism is positively correlated with tumor recurrence and can be used as an independent prognostic marker for HCC patients after operation. 29675105

2018

dbSNP: rs9912300
rs9912300
0.010 GeneticVariation BEFREE Although we did not find any significant results in total analysis (all p>0.05), our stratified data showed that SNP rs9912300 in ACLY gene was significantly associated with overall survival of HCC patients with lower AFP level and SNP rs11871275 in ACACA gene was significantly associated with overall survival of HCC patients with higher AFP level. 25735330

2015

dbSNP: rs9904341
rs9904341
0.010 GeneticVariation BEFREE No association between rs8073069, rs9904341 or rs1042489 in survivin gene and the risk of HCC is found in Chinese han population, but rs8073069G-rs9904341C- rs1042489T is perhaps a protective haplotype for HCC. 22214342

2012

dbSNP: rs988574
rs988574
0.010 GeneticVariation BEFREE Our study demonstrated that rs988574 of <i>ITGA1</i> and the expression of <i>ITGA5</i>, <i>ITGB5</i> and <i>ITGA2B</i> are potential independent prognostic bio-markers and therapeutic targets for HBV-related HCC patients and may be useful for the diagnosis of HBV-related HCC. 29100351

2017

dbSNP: rs9877457
rs9877457
0.010 GeneticVariation BEFREE Five polymorphisms (rs11929692, rs7644369, rs6776570, rs3821502, and rs6766459) of the EPHB1 gene and alleles of 2 polymorphisms (rs1502174 and rs9877457) were associated with HCC (p < 0.05 for both). 21763378

2011

dbSNP: rs985033810
rs985033810
T 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016

dbSNP: rs985033810
rs985033810
A 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016

dbSNP: rs975263
rs975263
0.010 GeneticVariation BEFREE Our data suggest that SNP rs1990172 and SNP rs975263 in the MACC1 gene may be potential genetic markers for HCC recurrence in LT patients. 24465159

2014

dbSNP: rs972427414
rs972427414
MPO
0.010 GeneticVariation BEFREE We assessed the influence of Ala16Val-superoxide dismutase 2, Pro198Leu-glutathione peroxidase 1, and -463G/A-myeloperoxidase genotypes (high activity for the Ala, Pro, and G alleles, respectively) on the risks of cirrhosis and hepatocellular carcinoma (HCC) in patients homozygous for the C282Y-hemochromatosis (HFE) gene mutation. 20673159

2011

dbSNP: rs9679162
rs9679162
0.060 GeneticVariation BEFREE N-acetylgalactosaminyltransferase 14 (GALNT14)-rs9679162 genotype is a prognostic predictor for chemotherapy response in advanced hepatocellular carcinoma. 27124048

2016

dbSNP: rs9679162
rs9679162
0.060 GeneticVariation BEFREE In conclusion, this prospective study confirmed that GALN14 genotype (rs9679162) was an effective predictor for therapeutic outcome in advanced HCC patients treated by FMP chemotherapy. 23959947

2014

dbSNP: rs9679162
rs9679162
0.060 GeneticVariation BEFREE The present study investigated the prognostic role of the N-acetylgalactosaminyltransferase 14 (<i>GALNT14</i>)-rs9679162 genotype, an effective therapeutic response predictor for hepatocellular carcinoma in patients with cholangiocarcinoma receiving surgical resection. 28588705

2017

dbSNP: rs9679162
rs9679162
0.060 GeneticVariation BEFREE Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma. 28695683

2018

dbSNP: rs9679162
rs9679162
0.060 GeneticVariation BEFREE A GALNT14 rs9679162 genotype-guided therapeutic strategy for advanced hepatocellular carcinoma: systemic or hepatic arterial infusion chemotherapy. 31611591

2020

dbSNP: rs9679162
rs9679162
0.060 GeneticVariation BEFREE The rs9679162 GALNT14 genotype is potentially associated with the objective response of the first course of FMP chemotherapy in patients with far advanced hepatocellular carcinoma. 21635146

2011

dbSNP: rs967461896
rs967461896
G 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016

dbSNP: rs967461896
rs967461896
C 0.700 GeneticVariation CLINVAR Identifying recurrent mutations in cancer reveals widespread lineage diversity and mutational specificity. 26619011

2016

dbSNP: rs9651118
rs9651118
0.010 GeneticVariation BEFREE In summary, our findings suggested that MTHFR rs3753584, rs9651118 and rs1801133 polymorphisms may affect the risk of HCC in Chinese Han population. 31694048

2019

dbSNP: rs964372
rs964372
0.010 GeneticVariation BEFREE Carriers with MT-1 rs8052394, rs964372, and rs8052334 A-G-T haplotype had a 2.25-fold (95 % confidence interval [CI] 1.46-3.26) risk for HCC development than the control group (A-C-T, the most common haplotype). 22805858

2013

dbSNP: rs9642880
rs9642880
0.010 GeneticVariation BEFREE These results illustrate the potential association between rs9642880 G > T and survival in HCC patients who received radiotherapy treatment. 29396413

2018